2012-05-12 19:22:55: Groundbreaking New Course in Mouse Pathobiology

May 03 2012 – The Center for Genomic Pathology and UC Davis Extension announce a new course in the online series Pathobiology of the Mouse: Mouse as a Model for Mammary Cancer. This groundbreaking course is the first in the second tier of the program and is designed for experienced investigators at the doctoral level working in mammary tumor biology. The course includes case studies and interactive conferences with expert faculty. Now open for enrollment, the course is scheduled to launch on June 11, 2012 Press Release

2011-01-29 18:18:05: RT-qPCR Guidelines: From Designing to Publishing Your Data

The Biotechnology Program Presents:

“RT-qPCR Guidelines: From Designing to Publishing Your Data”

Dr. Emir Hodzic, DVM, PhD

Director, Real-time PCR Research and Diagnostic Core Facility

Project Scientist, Center for Comparative Medicine, UC Davis

Monday, January 31^st, 2011

12:00pm – 1:10pm 1022 Life Sciences Addition

Abstract: Quantitative real-time PCR (qPCR) is a technique that is now commonly employed in almost all molecular biology laboratories to elucidate variation in gene expression.
But with the widespread use of such a wonderful and sensitive technology comes differences in how to obtain valuable and reportable results. The lack of quality control for publishing qPCR data is still lacking. To overcome this increasing problem of lack of consistency in publications, a panel of real-time PCR experts published a set of guidelines containing what they consider the minimal information required when reporting qPCR results. The Real-time PCR Research and Diagnostic Core Facility at UC Davis fully abides with the proposed MIQE guidelines, so this presentation presents an expanded explanation of the guideline items with commentary, based on our experience, on how those requirements might be met prior to publication.

Bio: Dr. Emir Hodzic received his D.V.M. and PhD. from the School of Veterinaty Medicine at the University of Sarajevo, Bosnia and Herzegovina. His postdoctoral training was with the Section of Comparative Medicine at Yale University School of Medicine in New Haven, CT where he studied animal models of Lyme disease and human Granulocytic Anaplasmosis. Dr. Hodzic is currently a director of the Real-time PCR Research and Diagnostic Core Facility as well as a project scientist for the Center for Comparative Medicine at UC Davis.

Contact the Biotechnology Program at 530-752-3260.

Why not get a Designated Emphasis in Biotechnology along with your PhD? For more information, contact the Biotechnology Program (biotechprogram@ucdavis.edu) or checkout our website: http://www.deb.ucdavis.edu/.

Sponsored by: The UC Davis Biotechnology Program